21 May 2013
Keywords: merck, co, sees, positive, data, mk-0518, drug
Article | 20 February 2006
US drug giant Merck & Co says that its investigational oral HIV integrase inhibitor MK 0518 has, so far, provided a greater ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 February 2006
13 February 2006
© 2013 thepharmaletter.com